Gene · 406967
Papers3,717
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,717
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Silver Nanoparticles in the Diagnosis and Treatment of Cancer: Are There Any Perspectives for the Future? | Life (Basel) | 2023 | 36836823 | PubTator, text mining | PubMed |
| Characterization and microRNA Expression Analysis of Serum-Derived Extracellular Vesicles in Severe Liver Injury from Chronic HBV Infection. | Life (Basel) | 2023 | 36836704 | PubTator, text mining | PubMed |
| Pediatric Diabetic Nephropathy: Novel Insights from microRNAs. | J Clin Med | 2023 | 36835983 | PubTator, text mining | PubMed |
| Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation. | Int J Mol Sci | 2023 | 36835428 | PubTator, text mining | PubMed |
| Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach. | Int J Mol Sci | 2023 | 36835424 | PubTator, text mining | PubMed |
| Modulation of AKT Pathway-Targeting miRNAs for Cancer Cell Treatment with Natural Products. | Int J Mol Sci | 2023 | 36835100 | PubTator, text mining | PubMed |
| Blood-Based Biomarkers for Eosinophilic Esophagitis and Concomitant Atopic Diseases: A Look into the Potential of Extracellular Vesicles. | Int J Mol Sci | 2023 | 36835081 | PubTator, text mining | PubMed |
| Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients. | Int J Mol Sci | 2023 | 36834570 | PubTator, text mining | PubMed |
| Malignancies in Patients with Celiac Disease: Diagnostic Challenges and Molecular Advances. | Genes (Basel) | 2023 | 36833303 | PubTator, text mining | PubMed |
| Could Long Non-Coding RNA MEG3 and PTENP1 Interact with miR-21 in the Pathogenesis of Non-Alcoholic Fatty Liver Disease? | Biomedicines | 2023 | 36831110 | PubTator, text mining | PubMed |
| Small RNA-Seq Transcriptome Profiling of Mesothelial and Mesothelioma Cell Lines Revealed microRNA Dysregulation after Exposure to Asbestos-like Fibers. | Biomedicines | 2023 | 36831074 | PubTator, text mining | PubMed |
| Nutritional Genomics in Nonalcoholic Fatty Liver Disease. | Biomedicines | 2023 | 36830856 | PubTator, text mining | PubMed |
| m6A Modification-Association with Oxidative Stress and Implications on Eye Diseases. | Antioxidants (Basel) | 2023 | 36830067 | PubTator, text mining | PubMed |
| Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review. | Noncoding RNA | 2023 | 36827542 | PubTator, text mining | PubMed |
| Exosomal non coding RNAs as a novel target for diabetes mellitus and its complications. | Noncoding RNA Res | 2023 | 36818396 | PubTator, text mining | PubMed |
| Biomarkers (mRNAs and non-coding RNAs) for the diagnosis and prognosis of rheumatoid arthritis. | Front Immunol | 2023 | 36817438 | PubTator, text mining | PubMed |
| Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism. | Front Pharmacol | 2023 | 36814494 | PubTator, text mining | PubMed |
| A Comprehensive Study on the Anti-cancer Effects of Quercetin and Its Epigenetic Modifications in Arresting Progression of Colon Cancer Cell Proliferation. | Arch Immunol Ther Exp (Warsz) | 2023 | 36807774 | PubTator, text mining | PubMed |
| New insights into KLFs and SOXs in cancer pathogenesis, stemness, and therapy. | Semin Cancer Biol | 2023 | 36806560 | PubTator, text mining | PubMed |
| A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes. | Clin Epigenetics | 2023 | 36803590 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406967/papers?page=20